Related Funds
Funds with similar focus
Fund Name | Location |
ADAP Seed Fund 2 | - |
ATB Financial | Alberta, Canada, Edmonton |
Beijing Guohuarong Network Technology | Beijing, Beijing, China |
Cheshire & Warrington | England, Somerset West and Taunton, United Kingdom |
Claridge | Canada, Montréal, Quebec |
Clover Capital Partners | Evanston, Illinois, United States |
Edge Investments | England, London, United Kingdom |
Enron Investment Partners | Houston, Texas, United States |
Idein Ventures | India, Maharashtra, Mumbai |
Korea Omega Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
Kunlun Fund | China, Hangzhou, Zhejiang |
Netscape | California, Mountain View, United States |
Redesign Health | New York, New York, United States |
Riverstone Energy | Castel, Guernsey, Guernsey |
Walker Ventures | Glenwood, Maryland, United States |
Wareness.io | New York, New York, United States |
Wildcat Venture Partners | California, San Mateo, United States |
Zhe Chuang Tou | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ImmuneOnco Biopharma | $15M | 11 Apr 2018 | Shanghai | ||
Biosis Healing | $12M | 16 Dec 2016 | Daxing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ImmuneOnco Biopharma | $15M | 11 Apr 2018 | Shanghai | ||
Biosis Healing | $12M | 16 Dec 2016 | Daxing, Beijing, China |